← signals
2026-07-07·NVDA·competitive threat
lowdown

As of July 7, 2026, Manifold Markets prediction consensus shows a 74.92% probability that China's AI chip sector will...

As of July 7, 2026, Manifold Markets prediction consensus shows a 74.92% probability that China's AI chip sector will make significant strides planting seeds for Nvidia's eventual decline Source 1.

window 60devidence 29confidence score 91price NVDA $194.83

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

NVDA has already moved down -12% over the recent 30-90 day window.

partly priced
as of 2026-07-027d n/a45d n/a90d +10%yahoo

signal brief

As of July 7, 2026, Manifold Markets prediction consensus shows a 74.92% probability that China's AI chip sector will make significant strides planting seeds for Nvidia's eventual decline Source 1. Meanwhile, a separate market assigns a 72.90% chance that a serious competitor to Nvidia in AI chips emerges before end of 2027 Source 20. Only a 12.50% probability is assigned to a China-domestic chip reaching 80% of H100 performance by end of 2026 Source 3, and a 24.55% chance that China develops a domestic GPU comparable to H100 by 2026 Source 28. These data points suggest market participants increasingly expect competitive pressure on Nvidia's dominant position in AI accelerators over the medium term.

What the sources said:

  • Source 1: "China’s AI chip sector make significant strides, planting seeds for eventual decline on Nvidia" — YES probability 74.92%.
  • Source 20: "Will a serious competitor to NVIDIA in the AI chip space emerge before EOY 2027?" — YES probability 72.90%.
  • Source 3: "Will any China-domestic AI chip reach ≥80% of NVIDIA H100 perf on a public benchmark before 2026-12-31?" — YES probability 12.50%.
  • Source 28: "Will China develop domestic GPU with comparable performance to NVIDIA H100 by 2026?" — YES probability 24.55%.

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.